Mitigating Risk for Medication Errors Involving Paxlovid
Paxlovid (a co-packaged product containing nirmatrelvir and ritonavir tablets) was recently approved by Health Canada for the treatment of mild to moderate COVID-19 in adults at high risk for progression to severe disease.
• Sharing Matters! Reported Concern Results in Safer Jardiance Product Labelling
• SafeMedicationUse.ca: Tips for Starting and Stopping Antidepressants Safely